Steve Schonfeld Schonfeld Strategic Advisors
Steve Schonfeld is the founder of Schonfeld Strategic Advisors, a multi-manager investment firm with roots in proprietary trading. Schonfeld allocates capital across quantitative and discretionary strategies with an emphasis on risk controls and diversification of return streams. The firm is a major name in the multi-strategy hedge fund landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NRG Energy
NRG
|
+$61.4M |
| 2 |
Vistra
VST
|
+$60.2M |
| 3 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$44.4M |
| 4 |
ConocoPhillips
COP
|
+$33.8M |
| 5 |
ETFC
E*Trade Financial Corporation
ETFC
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Conagra Brands
CAG
|
+$43.5M |
| 2 |
Target
TGT
|
+$30.5M |
| 3 |
Best Buy
BBY
|
+$28.2M |
| 4 |
Canadian Natural Resources
CNQ
|
+$23.9M |
| 5 |
APU
AmeriGas Partners, L.P.
APU
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.72% |
| 2 | Financials | 15.54% |
| 3 | Consumer Discretionary | 11.37% |
| 4 | Technology | 11.07% |
| 5 | Energy | 9.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Encompass Health
EHC
$11.9B
| $811K | 0.03% |
16,090
+1,760
| +12% | +$85.4K |
|
502
Sempra
SRE
$55.3B
| $811K | 0.03% |
11,800
-200
| -2% | -$13.1K |
|
503
Medifast
MED
$134M
| $808K | 0.03% |
+6,300
| New | +$875K |
|
504
Dentsply Sirona
XRAY
$2.17B
| $805K | 0.03% |
+13,800
| New | +$741K |
|
|
NGM
505
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $805K | 0.03% |
+55,000
| New | +$805K |
|
|
FBC
506
DELISTED
Flagstar Bancorp, Inc. New
FBC
| $805K | 0.03% |
+24,300
| New | +$809K |
|
507
AAR Corp
AIR
$5.42B
| $802K | 0.03% |
21,799
-30,001
| -58% | -$992K |
|
|
RETA
508
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $792K | 0.03% |
+8,400
| New | +$725K |
|
|
MNK
509
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $792K | 0.03% |
+86,300
| New | +$1.25M |
|
|
CDK
510
DELISTED
CDK Global, Inc.
CDK
| $784K | 0.03% |
15,861
-9,843
| -38% | -$527K |
|
511
Xerox
XRX
$374M
| $782K | 0.03% |
22,074
-13,457
| -38% | -$449K |
|
|
ZAYO
512
DELISTED
Zayo Group Holdings, Inc.
ZAYO
| $777K | 0.03% |
+23,600
| New | +$753K |
|
513
O'Reilly Automotive
ORLY
$73.4B
| $776K | 0.03% |
31,500
+4,305
| +16% | +$109K |
|
|
UFS
514
DELISTED
DOMTAR CORPORATION (New)
UFS
| $775K | 0.03% |
17,400
+4,580
| +36% | +$209K |
|
|
GHDX
515
DELISTED
Genomic Health, Inc.
GHDX
| $768K | 0.03% |
13,200
+500
| +4% | +$29.6K |
|
516
JetBlue
JBLU
$1.87B
| $767K | 0.03% |
+41,474
| New | +$742K |
|
|
517
Target
TGT
$77.2B
| $765K | 0.03% |
8,832
-377,968
| -98% | -$30.5M |
|
518
Jefferies Financial Group
JEF
$12B
| $764K | 0.03% |
44,397
-81,042
| -65% | -$1.39M |
|
519
Eli Lilly
LLY
$1.11T
| $764K | 0.03% |
6,900
-7,571
| -52% | -$892K |
|
|
SNBR
520
DELISTED
Sleep Number
SNBR
| $764K | 0.03% |
+18,900
| New | +$730K |
|
521
Ross Stores
ROST
$77.5B
| $762K | 0.03% |
+7,692
| New | +$750K |
|
522
Graham Holdings Company
GHC
$4.98B
| $759K | 0.03% |
1,100
-100
| -8% | -$69.8K |
|
523
Core Laboratories
CLB
$553M
| $758K | 0.03% |
+14,500
| New | +$850K |
|
524
Howmet Aerospace
HWM
$105B
| $756K | 0.03% |
38,158
+5,297
| +16% | +$89.4K |
|
525
CDW
CDW
$16.6B
| $755K | 0.03% |
6,804
-11,408
| -63% | -$1.2M |
|
Similar funds
Steve Schonfeld's Q2 2019 Portfolio in Review
As of Q2 2019, Steve Schonfeld held 1,400 positions worth $2.83B, down 1.8% from $2.88B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Steve Schonfeld withdrew a net $96.1M in Q2 2019, closing 442 positions and reducing 316 holdings. Its most notable exit was Conagra Brands, an estimated $43.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Steve Schonfeld opened a new position in Equitrans Midstream Corporation Common Stock worth $42.1M.
- Steve Schonfeld's largest Q2 2019 buy was Equitrans Midstream Corporation Common Stock: 2,136,064 shares worth $42.1M.
- Steve Schonfeld added most to NRG Energy in Q2 2019, an estimated $61.4M increase.
- Steve Schonfeld's biggest Q2 2019 reduction was Target, cutting an estimated $30.5M.
- Steve Schonfeld fully exited Conagra Brands in Q2 2019, selling an estimated $43.5M.
- Steve Schonfeld's ten largest holdings make up 16% of its $2.83B portfolio in Q2 2019.
- Steve Schonfeld opened 374 new positions and closed 442 in Q2 2019.
- Steve Schonfeld's portfolio value fell 1.8% quarter-over-quarter to $2.83B.
Based on Schonfeld Strategic Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.